1 |
Beck, C.F., Ingraham, J.L., Neuhard, J., and Thomassen, E. (1972). Metabolism of pyrimidines and pyrimidine nucleosides by Salmonella typhimurium. J. Bacteriol. 110, 219-228
|
2 |
Liu, Q.A. and Hengartner, M.O. (1999). The molecular mechanism of programmed cell death in C. elegans. Ann. N Y Acad. Sci. 887, 92-104
DOI
|
3 |
Longley, D.B., Harkin, D.P., and Johnston, P.G. (2003). 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews 3, 330-338
DOI
ScienceOn
|
4 |
Schumacher, B., Hofmann, K., Boulton, S., and Gartner, A. (2001). The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr. Biol. 11, 1722-1727
DOI
ScienceOn
|
5 |
Yoo, B.C., Jeon, E., Hong, S.H., Shin, Y.K., Chang, H.J., and Park, J.G. (2004). Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Clin. Cancer Res. 10, 4176-4184
DOI
ScienceOn
|
6 |
Pratt, S., Shepard, R.L., Kandasamy, R.A., Johnston, P.A., Perry, W., 3rd, and Dantzig, A.H. (2005). The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol. Cancer Ther. 4, 855-863
DOI
ScienceOn
|
7 |
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94
|
8 |
Clynes, M.M. and Duke, E.J. (1976). Altered pyrimidinesalvage metabolism in a 5-fluorouracil-resistant mutant of Drosophila melanogaster. Biochem. Soc. Trans. 4, 900-901
|
9 |
Rich, T.A., Shepard, R.C., and Mosley, S.T. (2004). Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J. Clin. Oncol. 22, 2214-2232
DOI
ScienceOn
|
10 |
Derry, W.B., Putzke, A.P., and Rothman, J.H. (2001). Caenor-habditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science 294, 591-595
DOI
|
11 |
Longley, D.B. and Johnston, P.G. (2005). Molecular mechanisms of drug resistance. J. Pathol. 205, 275-292
DOI
ScienceOn
|
12 |
Wicks, S.R., Yeh, R.T., Gish, W.R., Waterston, R.H., and Plasterk, R.H. (2001). Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat. Genet. 28, 160-164
DOI
ScienceOn
|
13 |
Maring, J.G., Groen, H.J., Wachters, F.M., Uges, D.R., and de Vries, E.G. (2005). Genetic factors influencing pyrimidine-antagonist chemotherapy. The pharmacogenomics j. 5, 226-243
DOI
ScienceOn
|
14 |
Peters, G.J., Backus, H.H., Freemantle, S., van Triest, B., Codacci- Pisanelli, G., van der Wilt, C.L., Smid, K., Lunec, J., Calvert, A.H., Marsh, S., et al. (2002). Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim. Biophys. Acta 1587, 194-205
DOI
ScienceOn
|
15 |
Hengartner, M.O. (1999). Programmed cell death in the nematode C. elegans. Recent progress in hormone research 54, 213-222; discussion 222-214
|
16 |
Davis, M.W., Hammarlund, M., Harrach, T., Hullett, P., Olsen, S., and Jorgensen, E.M. (2005). Rapid single nucleotide polymorphism mapping in C. elegans. BMC Genomics 6, 118
DOI
ScienceOn
|
17 |
Duke, E.J. and Glassman, E. (1968). Drug effects in Drosophila: streptomycin sensitive strains and fluorouracil resistant strains. Nature 220, 588-589
DOI
ScienceOn
|
18 |
Jund, R. and Lacroute, F. (1970). Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J. Bacteriol. 102, 607-615
|
19 |
Kern, L., de Montigny, J., Jund, R., and Lacroute, F. (1990). The FUR1 gene of Saccharomyces cerevisiae: cloning, structure and expression of wild-type and mutant alleles. Gene 88, 149-157
DOI
ScienceOn
|
20 |
Bean, B. and Tomasz, A. (1971). Inhibitory effects and metabolism of 5-fluoropyrimidine derivatives in pneumococcus. J. Bacteriol. 106, 412-420
|